This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Real Estate Companies: American Healthcare REIT, Inc. (AHR) and Federal Realty (FRT)

Tipranks - Tipranks - Wed May 27, 10:04AM CDT

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on American Healthcare REIT, Inc. (AHR) and Federal Realty (FRT) with bullish sentiments.

Memorial Day Sale – Claim 70% Off TipRanks

American Healthcare REIT, Inc. (AHR)

In a report released today, Farrell Granath from Bank of America Securities maintained a Buy rating on American Healthcare REIT, Inc.. The company’s shares closed last Tuesday at $50.40.

According to TipRanks.com, Granath is a 3-star analyst with an average return of 7.9% and a 73.1% success rate. Granath covers the NA sector, focusing on stocks such as National Health Investors, Healthpeak Properties, and Sabra Healthcare REIT. ;'>

American Healthcare REIT, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $57.26, which is a 13.2% upside from current levels. In a report issued on May 20, Morgan Stanley also maintained a Buy rating on the stock with a $50.81 price target.

See the top stocks recommended by analysts >>

Federal Realty (FRT)

BMO Capital analyst Juan C. Sanabria maintained a Buy rating on Federal Realty today and set a price target of $140.00. The company’s shares closed last Tuesday at $119.79.

According to TipRanks.com, Sanabria is a 4-star analyst with an average return of 3.3% and a 54.8% success rate. Sanabria covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., American Healthcare REIT, Inc., and National Storage Affiliates. ;'>

Federal Realty has an analyst consensus of Moderate Buy, with a price target consensus of $121.72, a 1.4% upside from current levels. In a report issued on May 14, J.P. Morgan also maintained a Buy rating on the stock with a $124.00 price target.

Read More on AHR:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).